Manufacturing: Page 51
-
Generic version of Diovan from India approved by FDA
This is the first generic version of the blood pressure drug available in the U.S.
By Nicole Gray • June 27, 2014 -
Deep Dive
4 takeaways about the U.S. biosimilars market
Take a deeper look at the emerging market, which could trigger a substantial reduction in key healthcare costs.
By Nicole Gray • June 26, 2014 -
Bayer, Dimension Therapeutics collaborating on hemophilia A gene therapy
If the treatment makes it to market, it will be a major game-changer for patients.
By Nicole Gray • June 25, 2014 -
Indian Health Ministry likely to expand list of essential medications, cap costs
The decision has major implications for American drug manufacturers.
By Nicole Gray • June 24, 2014 -
Companies collaborate to fight multidrug-resistant pathogens
A new diagnostic test is available in Europe and coming to the U.S., but that's just the first step.
By Nicole Gray • June 22, 2014 -
Deep Dive
Theory can outrun reality on drug approval fast track
The designation can create a buzz that is often not justified.
By Nicole Gray • June 20, 2014 -
FDA seeks to widen warning on testosterone products
The agency wants the products to include a warning about blood clots in veins.
By Randy Lilleston • June 20, 2014 -
J&J rachets up R&D through 12 new alliances
The company has many collaborations underway.
By Nicole Gray • June 20, 2014 -
J&J acquires global rights to influenza drug
If approved, the vaccine would be a new treatment approach to an age-old viral condition.
By Nicole Gray • June 20, 2014 -
NICE: More novel anticoagulant use could reduce strokes
The British agency has recommended adding novel anticoagulants to formularies throughout the UK.
By Nicole Gray • June 18, 2014 -
Pfizer, Novartis push for approval of meningitis vaccines
The two companies each have developed a vaccine to prevent a virulent form of meningitis.
By Nicole Gray • June 18, 2014 -
Pfizer expands research capacity with Cambridge, MA location
The firm is setting up a mega-research facility, bringing together industry, academic and the hospital system to collaborate on therapeutic innovation.
By Nicole Gray • June 18, 2014 -
Teva closing manufacturing sites to cut costs
As part of broader cost-cutting and streamlining measures, the company will close half of its manufacturing sites.
By Nicole Gray • June 18, 2014 -
Sanofi, Medtronic team up to offer options for diabetes patients
The new partnership focuses on innovative drug-device breakthroughs.
By Nicole Gray • June 17, 2014 -
Insulin 300 performs well in phase III trials
Will it beat its competitors?
By Nicole Gray • June 17, 2014 -
Deep Dive
As diabetes soars, so do research and treatment options
Currently, about 180 drugs are in development to address the diabetes-related challenges that persist despite available treatments.
By Nicole Gray • June 16, 2014 -
Medtronic buying Ireland-based Covidien
The merger will make Medtronic a mega-medical-device company.
By Nicole Gray • June 16, 2014 -
Parion, Santen bring dry eye drug to Asian markets
The drug has a novel mode of action and will help Parion build an Asian distribution network with a new partner.
By Nicole Gray • June 13, 2014 -
Deep Dive
Small companies may be key to big advances in malaria treatment
Malaria remains a major killer worldwide, and treatments quickly become ineffective because of resistance. On an industry level, smaller firms are taking on that challenge.
By Nicole Gray • June 13, 2014 -
Protein Sciences boosts influenza vaccine availability, distribution
In response to healthcare professionals who want access to Flublok ahead of the 2014-15 flu season, the company will make its recombinant vaccine available as early as September.
By Nicole Gray • June 13, 2014 -
Pharma leaders at Biovision discuss high costs of innovation
Executives from Sanofi and Johnson & Johnson discussed the underlying reasons that the cost of drug development, and by extension drug prices, seem high.
By Nicole Gray • June 10, 2014 -
GelStat gets medical marijuana foothold with Mastix Medica acquisition
The acquisition will bolster Gelstat's weight-loss chewing gum product line and allow the company to move into the high CBD/low THC market.
By Nicole Gray • June 10, 2014 -
Pfenex uses R&D prowess to develop AMD alternative to Lucentis
The company has brought its AMD candidate into clinical trials in just two years---and based on its high-throughput screening technology, there are many more candidate-concepts ready to be hatched.
By Nicole Gray • June 9, 2014 -
Frontage Labs to expand key facilities
The company will expand manufacturing, research and office-based facilities. Its role helping pharmaceutical companies advance research and development efforts is in high demand---and growing.
By Nicole Gray • June 5, 2014 -
Bayer, Orion partnering to develop prostate cancer drug
Bayer is trying to build a strong portfolio in this therapeutic area--and is off to a good start with Xofigo, which was approved last year.
By Nicole Gray • June 5, 2014
Previous
